Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck

R. B. Livingston, Lawrence Einhorn, M. A. Burgess, J. A. Gottlieb

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Squamous carcinoma of the head and neck is a problem commonly seen by the chemotherapist in regional cancer centers, usually after surgical and/or radiation therapy have been used to their fullest extent with ultimate failure to control the disease. In the current study, sequential combined drugs were employed in an attempt to achieve three major goals: (a) delay the development of clinically evident drug resistance and thus prolong responses; (b) make use of the most effective single agent, methotrexate, which is difficult to use in concert with other stomatitis producing agents like bleomycin and adriamycin; and (c) reduce morbidity and mortality related to treatment. It is important to emphasize that in this regimen, in order to attempt to delay drug resistance, the switch to the next part of the program was made at fixed predetermined intervals and did not require that advancing disease develop in the patient for the change to occur (although if early progression occurred, we did make the switch prematurely). A total of 28 patients with advanced, recurrent, squamous carcinoma of the head and neck who had received no prior chemotherapy were treated.

Original languageEnglish (US)
Pages (from-to)103-105
Number of pages3
JournalCancer Treatment Reviews
Volume60
Issue number1
StatePublished - 1976
Externally publishedYes

Fingerprint

Combination Drug Therapy
Drug Resistance
Squamous Cell Carcinoma
Neck
Head
Stomatitis
Bleomycin
Methotrexate
Doxorubicin
Radiotherapy
Morbidity
Drug Therapy
Mortality
Pharmaceutical Preparations
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research
  • Medicine(all)

Cite this

Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck. / Livingston, R. B.; Einhorn, Lawrence; Burgess, M. A.; Gottlieb, J. A.

In: Cancer Treatment Reviews, Vol. 60, No. 1, 1976, p. 103-105.

Research output: Contribution to journalArticle

Livingston, R. B. ; Einhorn, Lawrence ; Burgess, M. A. ; Gottlieb, J. A. / Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck. In: Cancer Treatment Reviews. 1976 ; Vol. 60, No. 1. pp. 103-105.
@article{933a5da3e9644c3b8028f629336d8c38,
title = "Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck",
abstract = "Squamous carcinoma of the head and neck is a problem commonly seen by the chemotherapist in regional cancer centers, usually after surgical and/or radiation therapy have been used to their fullest extent with ultimate failure to control the disease. In the current study, sequential combined drugs were employed in an attempt to achieve three major goals: (a) delay the development of clinically evident drug resistance and thus prolong responses; (b) make use of the most effective single agent, methotrexate, which is difficult to use in concert with other stomatitis producing agents like bleomycin and adriamycin; and (c) reduce morbidity and mortality related to treatment. It is important to emphasize that in this regimen, in order to attempt to delay drug resistance, the switch to the next part of the program was made at fixed predetermined intervals and did not require that advancing disease develop in the patient for the change to occur (although if early progression occurred, we did make the switch prematurely). A total of 28 patients with advanced, recurrent, squamous carcinoma of the head and neck who had received no prior chemotherapy were treated.",
author = "Livingston, {R. B.} and Lawrence Einhorn and Burgess, {M. A.} and Gottlieb, {J. A.}",
year = "1976",
language = "English (US)",
volume = "60",
pages = "103--105",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck

AU - Livingston, R. B.

AU - Einhorn, Lawrence

AU - Burgess, M. A.

AU - Gottlieb, J. A.

PY - 1976

Y1 - 1976

N2 - Squamous carcinoma of the head and neck is a problem commonly seen by the chemotherapist in regional cancer centers, usually after surgical and/or radiation therapy have been used to their fullest extent with ultimate failure to control the disease. In the current study, sequential combined drugs were employed in an attempt to achieve three major goals: (a) delay the development of clinically evident drug resistance and thus prolong responses; (b) make use of the most effective single agent, methotrexate, which is difficult to use in concert with other stomatitis producing agents like bleomycin and adriamycin; and (c) reduce morbidity and mortality related to treatment. It is important to emphasize that in this regimen, in order to attempt to delay drug resistance, the switch to the next part of the program was made at fixed predetermined intervals and did not require that advancing disease develop in the patient for the change to occur (although if early progression occurred, we did make the switch prematurely). A total of 28 patients with advanced, recurrent, squamous carcinoma of the head and neck who had received no prior chemotherapy were treated.

AB - Squamous carcinoma of the head and neck is a problem commonly seen by the chemotherapist in regional cancer centers, usually after surgical and/or radiation therapy have been used to their fullest extent with ultimate failure to control the disease. In the current study, sequential combined drugs were employed in an attempt to achieve three major goals: (a) delay the development of clinically evident drug resistance and thus prolong responses; (b) make use of the most effective single agent, methotrexate, which is difficult to use in concert with other stomatitis producing agents like bleomycin and adriamycin; and (c) reduce morbidity and mortality related to treatment. It is important to emphasize that in this regimen, in order to attempt to delay drug resistance, the switch to the next part of the program was made at fixed predetermined intervals and did not require that advancing disease develop in the patient for the change to occur (although if early progression occurred, we did make the switch prematurely). A total of 28 patients with advanced, recurrent, squamous carcinoma of the head and neck who had received no prior chemotherapy were treated.

UR - http://www.scopus.com/inward/record.url?scp=0017098650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017098650&partnerID=8YFLogxK

M3 - Article

C2 - 63330

AN - SCOPUS:0017098650

VL - 60

SP - 103

EP - 105

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 1

ER -